NCT01526330

Safety, Tolerability and Efficacy of YH14618 in Patients With Degenerative Disc Disease

A Double-blind, Randomized, Parallel, Placebo Controlled, Phase I/II Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH14618 Following Single Intradiscal Injection in Patients With Degenerative Disc Disease

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 48 (actual)
• Sponsor: Yuhan Corporation · Industry
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

The objective of this study is to assess the safety and tolerability of YH14618 during 24 weeks of follow-up period after single administration in patients with degenerative disc disease.

Conditions

• Degenerative Disc Disease

Interventions

Type	Name	Description
DRUG	YH14618	A mg/disc
DRUG	YH14618	B mg/disc
DRUG	YH14618	C mg/disc
DRUG	Placebo	0mg/disc

Timeline

• Start date: 2012-05-01
• Primary completion: 2014-01-01
• Completion: 2014-07-01
• First posted: 2012-02-03
• Last updated: 2015-05-29

Locations

1 site across 1 country: South Korea